Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 30 Sep 2026

POLICYBZR, full dossier

PB Fintech slumped 6.11% to Rs 1,081 on Tuesday, extending its decline to 42.69% in four trading sessions.

9 publishers have reported this development. Each act of reporting is below, cited.

The record

PB Fintech slumped 6.11% to Rs 1,081 on Tuesday, extending its decline to 42.69% in four trading sessions.

PB Fintech shares have plunged 42% in four sessions, wiping out Rs 37,000 crore in market value after IRDAI proposed reforms targeting insurance distribution and dark patterns.

indiatimes.com29 Sep 2026

PB Fintech shares fell over 6% on Tuesday, losing 43% in four straight sessions due to concerns over IRDAI's proposed insurance reforms.

moneycontrol.com29 Sep 2026

PB Fintech lost around ₹31,400 crore in market capitalisation over the two trading sessions ended September 25, as its shares plunged nearly 39% during the period.

fortuneindia.com25 Sep 2026

PB Fintech shares plunged a record 36% to a 52-week low, wiping out around Rs 31,430 crore in market value after IRDAI proposed changes to insurance commission structures.

indiatimes.com25 Sep 2026

The Insurance Regulatory and Development Authority of India (IRDAI) has proposed changes to insurance distribution that could lead to a major reset in the insurance sector.

businesstoday.in25 Sep 2026

The Insurance Regulatory and Development Authority of India (IRDAI) has proposed sweeping changes to commissions, expenses of management, and distribution practices.

fortuneindia.com25 Sep 2026

PB Fintech shares fell 20% after the Insurance Regulatory and Development Authority of India proposed changes to distributor commissions.

businesstoday.in24 Sep 2026

PB Fintech's share price fell by over 6% today and has lost about 40% in two straight sessions due to proposed regulatory changes.

livemint.com25 Sep 2026

PB Fintech shares plunged 36 percent on Thursday, September 24, wiping out more than Rs 31,000 crore from its market capitalisation, after IRDAI proposed changes to insurance distribution commissions and expense limits.

moneycontrol.com24 Sep 2026

PB Fintech shares plunged 30%, wiping out nearly Rs 26,200 crore from its market capitalisation after IRDAI proposed changes to insurance commission structures.

indiatimes.com24 Sep 2026

Insurance stocks witnessed heavy selling on Thursday, September 24, after the Insurance Regulatory and Development Authority of India (IRDAI) proposed significant changes to the way insurance is sold and how insurers and distributors can earn from policies.

Insurance stocks tumbled up to 10% after the Insurance Regulatory and Development Authority of India (IRDAI) proposed changes to insurance distribution, commission, and expense structures.

fortuneindia.com24 Sep 2026

PB Fintech shares crashed 32 per cent after the Insurance Regulatory and Development Authority of India (IRDAI) proposed changes to insurance distribution commissions.

zeebiz.com24 Sep 2026

PB Fintech plunged 30% to ₹1,320.10 after the Insurance Regulatory and Development Authority of India proposed an overhaul of insurance distribution economics.

fortuneindia.com24 Sep 2026

PB Fintech shares fell 28 percent to a day's low of Rs 1,360.80 on BSE after the Insurance Regulatory and Development Authority of India released a consultation paper on commissions, Expenses of Management, and distribution reforms.

businesstoday.in24 Sep 2026

PB Fintech and Turtlemint stocks fell sharply after the Insurance Regulatory and Development Authority of India (IRDAI) proposed changes to insurance distribution structures, expenses, commissions, market conduct, and transparency.

moneycontrol.com24 Sep 2026

PB Fintech shares plunged 36% on Thursday, wiping out ₹31,426 crore in market value after IRDAI proposed tighter curbs on commissions and insurers’ management expenses.

cnbctv18.com24 Sep 2026

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.